Zisman, D A <br/><br/>
Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.  [electronic resource] 

 -  Shock (Augusta, Ga.)  Nov 1997 
 - 349-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-2322 
<br/><br/><label>Standard No.: </label>10.1097/00024382-199711000-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Ascitic Fluid--microbiology<br/>Bacteremia--etiology<br/>Base Sequence<br/>Colony Count, Microbial<br/>DNA Primers--genetics<br/>Disease Models, Animal<br/>Endotoxemia--etiology<br/>Escherichia coli--immunology<br/>Escherichia coli Infections--immunology<br/>Female<br/>Gene Expression<br/>Immunization, Passive<br/>Interferon-gamma--antagonists & inhibitors<br/>Interleukin-12--antagonists & inhibitors<br/>Macrophages, Alveolar--immunology<br/>Mice<br/>Peritonitis--immunology<br/>RNA, Messenger--genetics<br/>Sepsis--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors